Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epi... by K. Morimoto, T. Yamada, N. Furuya, H. Tanaka, A. Yoshimura, T. Oba, M. Hibino, T. Fukuda, Y. Goto, A. Nakao, S. Ogusu, Y. Okazaki, T. Harada, T. Ota, K. Masubuchi, K. Mikami, T. Hata, S. Matsumoto, R. Honda, K. Date, Y. Chihara, K. Takayama

Get full text